Bharat Book

Ovarian Cancer - Pipeline Review, H2 2013

Press Release   •   Dec 07, 2013 10:27 IST

Dec 07, 2013 : Bharat Book Bureau presents the new report, on 'Ovarian Cancer - Pipeline Review, H2 2013  also reviews key players involved in the therapeutic development for Ovarian Cancer. Ovarian Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Ovarian Cancer.
- A review of the Ovarian Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Ovarian Cancer pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Ovarian Cancer.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Ovarian Cancer pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

Bristol-Myers Squibb Company
Johnson & Johnson
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Kyowa Hakko Kirin Co., Ltd.
Amgen Inc.
Sanofi-Aventis
AstraZeneca PLC
Eli Lilly and Company
Viralytics Ltd.
GlaxoSmithKline plc
Bioniche Life Sciences, Inc.
Tekmira Pharmaceuticals Corp.
Genentech, Inc.
Nektar Therapeutics
Bavarian Nordic A/S
Daiichi Sankyo Company, Ltd
Merck & Co., Inc.
AbGenomics International, Inc.
FASgen, Inc.
Dainippon Sumitomo Pharma Co., Ltd.
Oxford BioMedica plc
Generex Biotechnology Corporation
Amorfix Life Sciences Ltd.
Prolexys Pharmaceuticals, Inc.
Aposense Ltd.
Millennium Pharmaceuticals, Inc.
Novartis AG
Samyang Corporation
Aphios Corporation
Astellas Pharma Inc.
Chong Kun Dang Pharmaceutical
Eisai Co., Ltd.
ImmunoGen, Inc.
Pfizer Inc.
Sigma-Tau S.p.A.
Sunesis Pharmaceuticals, Inc.
SuperGen, Inc.
Taiho Pharmaceutical Co., Ltd.
Cell Therapeutics, Inc.
Santaris Pharma A/S
Exelixis, Inc.
Aduro BioTech
Menarini Group
Alfacell Corporation
Celgene Corporation
Onyx Pharmaceuticals, Inc.
Bayer AG
AntiCancer, Inc.
Merck KGaA
Access Pharmaceuticals, Inc.
Advaxis, Inc.
Neogenix Oncology Corporation
EntreMed, Inc.
Hana Biosciences, Inc.
Celldex Therapeutics, Inc.
ValiRx Plc
AEterna Zentaris Inc.
ImmunoCellular Therapeutics, Ltd.
IMMUNOMEDICS, INC
Lorus Therapeutics Inc
Marshall Edwards, Inc.
Basilea Pharmaceutica Ltd.
Bionomics Limited
Northwest Biotherapeutics, Inc.
Novogen Limited
Cleveland BioLabs, Inc.
Oncolytics Biotech Inc.
OXiGENE, Inc.
Critical Outcome Technologies Inc.
Alnylam Pharmaceuticals, Inc
Cytokinetics, Inc
Telik, Inc.
VioQuest Pharmaceuticals, Inc.
Oncogenex Pharmaceuticals, Inc.
Dendreon Corporation
Prima BioMed Limited
Progen Pharmaceuticals Limited
Innocell Corporation
PharmaGap Inc.

Table of contents :

Table of Contents 2
List of Tables 7
List of Figures 12
Introduction 13
Global Markets Direct Report Coverage 13
Ovarian Cancer Overview 14
Therapeutics Development 15
An Overview of Pipeline Products for Ovarian Cancer 15
Ovarian Cancer Therapeutics under Development by Companies 17
Ovarian Cancer Therapeutics under Investigation by Universities/Institutes 30
Late Stage Products 33
Comparative Analysis 33
Mid Clinical Stage Products 34
Comparative Analysis 34
Early Clinical Stage Products 35
Comparative Analysis 35
Discovery and Pre-Clinical Stage Products 36
Comparative Analysis 36
Ovarian Cancer Therapeutics - Products under Development by Companies 37
Ovarian Cancer Therapeutics - Products under Investigation by Universities/Institutes 55
Companies Involved in Ovarian Cancer Therapeutics Development 58
Bristol-Myers Squibb Company 58
Johnson & Johnson 59
Boehringer Ingelheim GmbH 60
F. Hoffmann-La Roche Ltd. 61
Kyowa Hakko Kirin Co., Ltd. 62
Amgen Inc. 63
Sanofi-Aventis 64
AstraZeneca PLC 65
Eli Lilly and Company 66
Viralytics Ltd. 67
GlaxoSmithKline plc 68
Bioniche Life Sciences, Inc. 69
Tekmira Pharmaceuticals Corp. 70
Genentech, Inc. 71
Nektar Therapeutics 72
Bavarian Nordic A/S 73
Daiichi Sankyo Company, Ltd 74
Merck & Co., Inc. 75
AbGenomics International, Inc. 76
FASgen, Inc. 77
Dainippon Sumitomo Pharma Co., Ltd. 78
Oxford BioMedica plc 79
Generex Biotechnology Corporation 80
Amorfix Life Sciences Ltd. 81
Prolexys Pharmaceuticals, Inc. 82
Aposense Ltd. 83
Millennium Pharmaceuticals, Inc. 84
Novartis AG 85
Samyang Corporation 86
Aphios Corporation 87
Astellas Pharma Inc. 88
Chong Kun Dang Pharmaceutical 89
Eisai Co., Ltd. 90
ImmunoGen, Inc. 91
Pfizer Inc. 92
Sigma-Tau S.p.A. 93
Sunesis Pharmaceuticals, Inc. 94
SuperGen, Inc. 95
Taiho Pharmaceutical Co., Ltd. 96
Cell Therapeutics, Inc. 97
Santaris Pharma A/S 98
Exelixis, Inc. 99
Aduro BioTech 100
Menarini Group 101
Alfacell Corporation 102
Celgene Corporation 103

For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/ovarian-cancer-pipeline-review-h2-20131.html

Related link : http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/ 


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.